AdvisorShares Athena Buy or Sell Recommendation

    Macroaxis provides AdvisorShares Athena High Dividend ETF buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AdvisorShares Athena positions. The advice algorithm takes into account all of AdvisorShares Athena High Dividend ETF available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AdvisorShares Athena buy-and-hold prospective. Additionally see Investing Opportunities.

    Time Horizon

    Risk Tolerance

    Execute Advice
    AdvisorShares Athena High Dividend ETF -- USA Athena High Dividend ETF  

    USD 18.93  0.76  4.18%

    Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AdvisorShares Athena High Dividend ETF is 'Not Rated'.
    For the selected time horizon AdvisorShares Athena High Dividend ETF has a risk adjusted performance of 0.2267, jensen alpha of 0.1857, total risk alpha of 0.2629, sortino ratio of 0.2888 and treynor ratio of 0.8898
    This buy or sell advice tool can be used to cross verify current analyst consensus on AdvisorShares Athena and to analyze the athena high dividend etf potential to grow in the current economic cycle. Please makes use of AdvisorShares Athena Price to Earning and Year to Date Return to make buy, hold, or sell decision on AdvisorShares Athena.

    Returns Distribution Density

    Mean Return0.17Value At Risk1.32
    Potential Upside2.26Standard Deviation1.27
     Return Density 
    Not Rated
    Alpha Finder
    Use alpha and beta coefficients to find investment opportunities after accounting for the risk
    Find Alpha
    Equity Screener
    Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
    Research Equities
    Insiders Screener
    Find insiders across different sectors to evaluate their impact on performance and growth of their entities
    Research Insiders